• Profile
Close

MRI, clinical examination, and mammography for preoperative assessment of residual disease and pathologic complete response after neoadjuvant chemotherapy for breast cancer: Acrin 6657 trial

American Journal of Roentgenology May 06, 2018

Scheel JR, et al. - Experts ascertained the accuracy of preoperative measurements for detecting the pathologic complete response (CR) and evaluating residual disease following neoadjuvant chemotherapy (NACT) in patients with locally advanced breast cancer. They noted greater efficacy of measurement of longest diameter by MRI than by mammography and clinical examination for preoperative assessment of tumour residua after NACT and could improve surgical planning.

Methods

  • Women with ≥ 3 cm invasive breast cancer receiving NACT, were prospectively enrolled in the American College of Radiology Imaging Network 6657 Trial.
  • Longest diameter by mammography, MRI, and clinical examination and functional volume on MRI were included in the preoperative measurements of residual disease.
  • Authors assessed the accuracy of preoperative measurements for detecting pathologic CR and the association with final pathology size for all lesions, separately for single masses and nonmass enhancements (NMEs), multiple masses, and lesions without ductal carcinoma in situ (DCIS).

Results

  • As per data, in the 138 women with all 4 preoperative measures, longest diameter by MRI demonstrated the highest accuracy for detecting pathologic CR for all lesions and NME (AUC = 0.76 and 0.84, respectively).
  • Findings suggested that in the accuracy of detecting pathologic CR for single masses, there was little difference across preoperative measurements (AUC = 0.69–0.72).
  • Results demonstrated that moderate ability for detecting pathologic CR for multiple masses was demonstrated with longest diameter by MRI and longest diameter by clinical examination (AUC = 0.78 and 0.74), and longest diameter by MRI and longest diameter by mammography demonstrated moderate ability for detecting pathologic CR for tumors without DCIS (AUC = 0.74 and 0.71).
  • In subjects with residual disease, the strongest association of longest diameter by MRI with pathology size for all lesions and single masses was seen (r=0.33 and 0.47).
  • Researchers noted no significant influence of tumor subtype or maphic densimmograty on associations between preoperative measures and pathology results.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay